Trial Profile
Open Label Pilot Study on Gene Expression Profiling of the Endometrial Tissue in Patients Undergoing Assisted Reproductive Technology (ART: IVF/ICSI) With GONAL-f.
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 01 Apr 2022
Price :
$35
*
At a glance
- Drugs Choriogonadotropin alfa (Primary) ; Follitropin alfa (Primary) ; LHRH receptor agonists; LHRH receptor antagonists
- Indications Female infertility
- Focus Pharmacogenomic; Therapeutic Use
- Acronyms EXPRESS
- Sponsors Merck KGaA
- 03 Jul 2012 Additional lead trial centre added as reported by ClinicalTrials.gov.
- 03 Jul 2012 Planned end date changed from 25 Sep 2009 to 1 Aug 2010 as reported by ClinicalTrials.gov.
- 17 Mar 2012 Planned patient number is 60 according to European Clinical Trials Database.